Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS–Sponsored by AbbVie Medical Affairs
Drs. Pendleton Wickersham (Arthritis Associates PA, San Antonio, TX), Kevin Winthrop (OHSU, Portland, OR), and Christopher Ritchlin (URMC, Rochester, NY) come together to share their experiences discu...
Perspectives on the safety of a JAK inhibitor in RA, PsA, and AS–Sponsored by AbbVie Medical Affairs
Rheumnow Podcast
Read the original at soundcloud.com
Keep up with this source
Keep this source in your dashboard and return to its latest articles. Email alerts are managed separately in Settings.
FetchFeeds groups articles by feed so you can follow sources, compare coverage, and save stories for later.
Back to all articles from Rheumnow PodcastMore from this feed
Choose another story from Rheumnow Podcast.
